Navigation Links
Catalent Expert Invited by Tufts University to Discuss Challenges and Innovative Clinical Supply Chain Solutions at DIA 2016 Conference
Date:6/23/2016

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Eric Valentine, Global Director, Clinical Distribution Services, has been invited by Tufts University to contribute to a roundtable discussion at the upcoming DIA 2016 Annual Meeting, to be held at the Pennsylvania Convention Center, Philadelphia, on June 26th – 30th 2016.

The session, chaired by Mary Jo Lamberti, from the Tufts Center for the Study of Drug Development at Tufts University School of Medicine, takes place on Tuesday June 28th, at 2.00 p.m., and will discuss a recent study conducted by the Center which gathered metrics on the impact of clinical supply logistics on global studies among 14 biopharmaceutical, CRO, and provider companies.

Mr. Valentine will be one of the experts on the panel who will review the study and discuss the strategies that companies use to optimize distribution networks, and give insight into shipping practices and approaches to investigational drugs and supplies, as well as identifying performance indicators for successful distribution strategies.

Mr. Valentine is responsible for developing the facility network and logistics strategies in support of Catalent's Clinical Supply Services business. He has a background that includes 20 years' experience serving in leadership positions in the CRO and drug development services industries. Mr. Valentine holds an MBA in Finance from Seton Hall University, New Jersey, and a B.A. in Business Administration from the University of Vermont.

For more information on the DIA 2016 Annual Meeting, visit: http://www.diaglobal.org/en/flagship/dia-2016/about/conference and to arrange a meeting with Mr. Valentine at the event, contact Richard Kerns at NEPR- richard(at)nepr(dot)eu.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2016/06/prweb13508823.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
2. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
3. Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
4. Catalent and Minomic Collaborate to Bring New Prostate Cancer Treatment to Market
5. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
6. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
7. Catalent Announces Two Senior Appointments to its Biologics Business
8. Bioavailability and Controlled Release Symposium Announced by Catalent Applied Drug Delivery Institute
9. Best Practice and Strategies in Risk Mitigation to be Presented by Catalent Expert at Internal Audit Summit
10. New OptiPact™ Technology Introduced by Catalent
11. Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 02, 2020 , ... Allegheny Health Network (AHN) ... Chief Medical Information Officer (CMIO), effective immediately. Dr. Lee succeeds Robert White, MD, ... AHN through the end of the year to help support a seamless transition. , ...
(Date:7/1/2020)... ... ... Dexur’s analysis of Medicare claims of hospitals within a 25-mile radius ... and Sky Ridge Medical Center had the best value outcomes ... patient’s episode of care from the date of admission for 90 days and includes ...
(Date:7/1/2020)... ... 01, 2020 , ... Psilera Bioscience (“Psilera”), a ... announces its core executive team. The co-founders Drs. Jackie Salm and Chris Witowski ... as distinguished researchers within the cannabis industry. They are joined by pharmaceutical and ...
(Date:7/1/2020)... ... July 01, 2020 , ... G-CON Manufacturing, the leader ... Codiak BioSciences to support its cleanroom build out at its new clinical manufacturing ... drug substance and product manufacturing for its clinical pipeline. , Codiak chose PODs ...
(Date:6/28/2020)... ... June 26, 2020 , ... Medisend ... provide high-quality, intensive education and training that prepares graduates for professional careers as ... member of the Board of Trustees. , Ms. Williams currently serves as Associate ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... (PRWEB) , ... July 02, 2020 , ... Exercise.com, the ... professionals, announced that 913,628,072 lifted pounds were logged through its software during the months ... this new age of fitness – an age where even gym giants like ...
(Date:7/1/2020)... , ... July 01, 2020 , ... Dexur’s analysis of ... University Hospitals Ahuja Medical Center , Southwest General Health Center , and ... episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of ...
(Date:6/28/2020)... ... June 28, 2020 , ... Probiotics ... studies substantiate the effectiveness of oral-care probiotics to maximize teeth and gum health. ... science behind both is simple – utilizing naturally occurring positive bacteria to improve ...
Breaking Medicine Technology: